QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
NASDAQ:BRKR

Bruker - BRKR Stock Forecast, Price & News

$70.12
+0.32 (+0.46%)
(As of 01/31/2023 12:00 AM ET)
Add
Compare
Today's Range
$69.16
$70.73
50-Day Range
$63.75
$73.03
52-Week Range
$48.42
$74.94
Volume
677,260 shs
Average Volume
635,918 shs
Market Capitalization
$10.31 billion
P/E Ratio
38.32
Dividend Yield
0.28%
Price Target
$74.00

Bruker MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
5.5% Upside
$74.00 Price Target
Short Interest
Bearish
3.13% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.48
Upright™ Environmental Score
News Sentiment
0.77mentions of Bruker in the last 14 days
Based on 6 Articles This Week
Insider Trading
Selling Shares
$1.39 M Sold Last Quarter
Proj. Earnings Growth
9.05%
From $2.32 to $2.53 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.36 out of 5 stars

Computer And Technology Sector

197th out of 631 stocks

Analytical Instruments Industry

8th out of 27 stocks


BRKR stock logo

About Bruker (NASDAQ:BRKR) Stock

Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation has a collaboration with Newomics Inc. on a LC-MS platform for drug discovery. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Receive BRKR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bruker and its competitors with MarketBeat's FREE daily newsletter.

BRKR Stock News Headlines

The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
Brokerages Set Bruker Co. (NASDAQ:BRKR) Target Price at $74.00
Bruker acquires ACQUIFER Imaging GmbH
The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
Bruker Announces Acquisition of ACQUIFER Imaging GmbH
Bruker Third Quarter 2022 Earnings: Beats Expectations
Bruker Reports Third Quarter 2022 Financial Results
Bruker (BRKR) Q3 Earnings and Revenues Surpass Estimates
See More Headlines
Receive BRKR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bruker and its competitors with MarketBeat's FREE daily newsletter.

BRKR Company Calendar

Last Earnings
11/03/2022
Ex-Dividend for 12/16 Dividend
11/30/2022
Dividend Payable
12/16/2022
Today
1/31/2023
Next Earnings (Estimated)
2/10/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
Life Sciences Tools & Services
Current Symbol
NASDAQ:BRKR
CUSIP
11679410
Employees
7,765
Year Founded
1960

Price Target and Rating

Average Stock Price Forecast
$74.00
High Stock Price Forecast
$85.00
Low Stock Price Forecast
$60.00
Forecasted Upside/Downside
+5.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

Net Income
$277.10 million
Pretax Margin
16.46%

Debt

Sales & Book Value

Annual Sales
$2.42 billion
Cash Flow
$2.65 per share
Book Value
$7.15 per share

Miscellaneous

Free Float
106,488,000
Market Cap
$10.31 billion
Optionable
Optionable
Beta
1.18

Social Links


Key Executives

  • Dr. Frank H. Laukien Ph.D. (Age 63)
    Chairman, CEO & Pres
    Comp: $2.44M
  • Mr. Gerald N. Herman (Age 65)
    Exec. VP & CFO
    Comp: $1.08M
  • Dr. Mark R. Munch Ph.D. (Age 61)
    Corp. Exec. VP and Pres of Bruker Nano Group & Corp.
    Comp: $1.54M
  • Mr. Juergen Srega (Age 68)
    Pres of Bruker CALID Group & Bruker Daltonics Division
    Comp: $960.8k
  • Dr. Falko Busse Ph.D. (Age 56)
    Pres of Bruker BioSpin Group
    Comp: $738.54k
  • Mr. Justin Joseph Ward
    Sr. Director of Investor Relations & Corp. Devel.
  • Mr. J. Brent Alldredge J.D. (Age 48)
    Gen. Counsel
  • Mr. Collin J. D'Silva (Age 66)
    Pres of Chemical Analysis Division
  • Stacey Desrochers
    Treasurer & Director of Investor Relations
  • Mr. Urban Faeh
    Pres of Bruker Optics Division & Managing Director of Bruker Optik GmbH













BRKR Stock - Frequently Asked Questions

Should I buy or sell Bruker stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last twelve months. There are currently 1 sell rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" BRKR shares.
View BRKR analyst ratings
or view top-rated stocks.

What is Bruker's stock price forecast for 2023?

4 Wall Street analysts have issued 1-year price objectives for Bruker's shares. Their BRKR share price forecasts range from $60.00 to $85.00. On average, they anticipate the company's stock price to reach $74.00 in the next twelve months. This suggests a possible upside of 5.5% from the stock's current price.
View analysts price targets for BRKR
or view top-rated stocks among Wall Street analysts.

How have BRKR shares performed in 2023?

Bruker's stock was trading at $68.35 at the beginning of 2023. Since then, BRKR stock has increased by 2.6% and is now trading at $70.12.
View the best growth stocks for 2023 here
.

When is Bruker's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, February 10th 2023.
View our BRKR earnings forecast
.

How were Bruker's earnings last quarter?

Bruker Co. (NASDAQ:BRKR) released its quarterly earnings results on Thursday, November, 3rd. The medical research company reported $0.66 EPS for the quarter, topping the consensus estimate of $0.53 by $0.13. The medical research company earned $638.90 million during the quarter, compared to the consensus estimate of $613.53 million. Bruker had a net margin of 10.97% and a trailing twelve-month return on equity of 32.58%.

How often does Bruker pay dividends? What is the dividend yield for Bruker?

Bruker declared a quarterly dividend on Friday, November 11th. Shareholders of record on Thursday, December 1st will be paid a dividend of $0.05 per share on Friday, December 16th. This represents a $0.20 annualized dividend and a dividend yield of 0.29%. The ex-dividend date of this dividend is Wednesday, November 30th.
Read our dividend analysis for BRKR
.

Is Bruker a good dividend stock?

Bruker (NASDAQ:BRKR) pays an annual dividend of $0.20 per share and currently has a dividend yield of 0.28%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 10.93%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, BRKR will have a dividend payout ratio of 7.91% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for BRKR.

What guidance has Bruker issued on next quarter's earnings?

Bruker issued an update on its FY 2022 earnings guidance on Thursday, November, 10th. The company provided earnings per share (EPS) guidance of $2.29-$2.33 for the period, compared to the consensus estimate of $2.29. The company issued revenue guidance of $2.45 billion-$2.50 billion, compared to the consensus revenue estimate of $2.50 billion.

What is Frank H. Laukien's approval rating as Bruker's CEO?

126 employees have rated Bruker Chief Executive Officer Frank H. Laukien on Glassdoor.com. Frank H. Laukien has an approval rating of 54% among the company's employees. This puts Frank H. Laukien in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. 79.0% of employees surveyed would recommend working at Bruker to a friend.

What other stocks do shareholders of Bruker own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bruker investors own include AbbVie (ABBV), CVS Health (CVS), Micron Technology (MU), Cisco Systems (CSCO), Intel (INTC), Alibaba Group (BABA), Walt Disney (DIS), Applied Materials (AMAT), Bank of America (BAC) and Bristol-Myers Squibb (BMY).

What is Bruker's stock symbol?

Bruker trades on the NASDAQ under the ticker symbol "BRKR."

Who are Bruker's major shareholders?

Bruker's stock is owned by many different institutional and retail investors. Top institutional investors include New York State Common Retirement Fund (0.19%), Mckinley Capital Management LLC Delaware (0.05%), Yousif Capital Management LLC (0.03%), Comerica Bank (0.03%), State of Alaska Department of Revenue (0.03%) and New York State Teachers Retirement System (0.03%). Insiders that own company stock include Cynthia M Friend, Frank H Laukien, Marc A Kastner, Mark Munch and Richard A Packer.
View institutional ownership trends
.

How do I buy shares of Bruker?

Shares of BRKR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Bruker's stock price today?

One share of BRKR stock can currently be purchased for approximately $70.12.

How much money does Bruker make?

Bruker (NASDAQ:BRKR) has a market capitalization of $10.31 billion and generates $2.42 billion in revenue each year. The medical research company earns $277.10 million in net income (profit) each year or $1.83 on an earnings per share basis.

How many employees does Bruker have?

The company employs 7,765 workers across the globe.

Does Bruker have any subsidiaries?
The following companies are subsidiares of Bruker: Accel Instruments, Advances Diagnostic Solutions Pty. Ltd., Agapetus GmbH, Alicona Corporation, Alicona GmbH, Alicona Imaging, Alicona Imaging GmbH, Alicona Korea Pcific Ltd., Alicona Manufacturing Inc., Alicona SARL, Alicona UK Limited, Alicona s.r.l., Anasys Instruments Corporation, Anasys Instruments GmbH, Arxspan, Biocentra AS., Bruker (Beijing) Scientific Technology Co. Ltd., Bruker (Malaysia) SDN BHD, Bruker AXS GmbH, Bruker AXS Handheld Inc., Bruker AXS LLC, Bruker AXS Ltd., Bruker Advanced Supercon GmbH, Bruker Austria GmbH, Bruker Belgium S.A./N.V., Bruker BioSciences Securities Corporation, Bruker BioSpin AG, Bruker BioSpin Corporation, Bruker BioSpin GmbH, Bruker BioSpin K.K., Bruker BioSpin MRI GmbH, Bruker Business Support Center sp. z o.o, Bruker Daltonics GmbH, Bruker Daltonics Ltd., Bruker Daltonics Pty. Ltd., Bruker Daltonics S.r.l., Bruker Daltonik GmbH, Bruker Detection Corporation, Bruker EAS GmbH, Bruker Energy & Supercon Technologies Inc. , Bruker Espanola S.A., Bruker Finance B.V., Bruker France S.AS., Bruker HTS GmbH, Bruker India Scientific PVT Ltd., Bruker Invest AG, Bruker Italia S.r.l., Bruker JV Israel Ltd., Bruker JV UK Ltd., Bruker Korea Co. Ltd., Bruker Ltd., Bruker Mexicana S.A. de C.V., Bruker MicroCT N.V., Bruker Nano GmbH, Bruker Nano Inc., Bruker Nederland B.V., Bruker Nordic AB, Bruker OST LLC, Bruker Optics GmbH, Bruker Optics Inc. , Bruker Optik GmbH, Bruker PTY Ltd., Bruker Physik GmbH, Bruker Polska Sp. Z o.o., Bruker Portugal Unipessoal LDA, Bruker Scientific Instruments Hong Kong Co. Ltd., Bruker Scientific Israel Ltd., Bruker Scientific LLC, Bruker Singapore Pte. Ltd., Bruker South Africa (Pty) Ltd., Bruker Taiwan Co. Ltd., Bruker Turkey Teknolojik Sistemler Ticaret Ltd. Sirketi, Bruker UK Ltd., Bruker do Brasil Ltda., Bruker s.r.o., Hain LifeScience E.A. Ltd., Hain LifeScience GmbH, Hain LifeScience Solutions (Pty) Ltd., Hain LifeScience Spain S.L., Hain LifeScience UK Ltd., Hain LifeSciences S.A. Pty Ltd., Hydrostatic Extrusions Ltd., Hysitron, InCoaTec GmbH, InVivo Biotech Services GmbH, InVivo Biotech Svs GmbH, JPK Instruments Limited, JPK Instruments USA. Inc., JPK In­stru­ments, JUWE Laborgeraete, Jordan Valley Semiconductors, Keymaster Technologies, Luxendo, Luxendo GmbH, MAC Science, Merlin Diagnostika GmbH, Mestrelab Research S.L., Michrom Bioresources, Oncovision - Innovative Medical Imaging, PMOD Technologies, Prairie Technologies, Princeton Gamma-Tech Instruments Inc, Quantron, RI Research Instruments GmbH, Roentec AG, S.I.S. Surface Imaging Systems, SAS Biocentric, SCiLS GmbH, SkyScan, Socabim, VACUUMSCHMELZE GmbH & Co. KG, Vutara LLC, XGLabs S.r.l., and Yingsheng Technology.
Read More
How can I contact Bruker?

Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The official website for the company is www.bruker.com. The medical research company can be reached via phone at (978) 663-3660, via email at investor.relations@bruker.com, or via fax at 978-663-5585.

This page (NASDAQ:BRKR) was last updated on 1/31/2023 by MarketBeat.com Staff